Aims Heart failure (HF) patients increasingly receive device therapy, either an implantable cardioverter defibrillator (ICD) or a biventricular pacemaker, also called cardiac resynchronization therapy (CRT), or a CRT device with an ICD (CRT-D). However, epidemiological data on the use of device therapy in Europe are limited. Methods and results Data on implantation rates for conventional pacemakers, ICD, CRT, and CRT-D in 15 Western European countries were obtained from the Eucomed Registry for the 5-year period 2004-2008. Implantation of conventional pacemakers increased by 9 in Europe over the 5 years (reaching 907/million in 2008) and there were significant differences between countries. Implantable cardioverter defibrillator implantations increased by 75 from 80/million in 2004 to 140/million in 2008, and differences between countries were larger than those for conventional pacemakers. Implantation rates for CRT-P alone increased slightly from 2004 to 2006, but remained at 25/million thereafter in Europe overall. The total number of CRT implants (CRT-P and-D) markedly increased from 46/million in 2004 to 99/million in 2008 (115), but this was mainly due to more CRT-D implants, i.e. an increase in the proportion of CRT-D (from 55 in 2004 to 75 in 2008). Implantation rates for ICD, CRT, and CRT-D remained markedly different throughout the study period between countries. Conclusion Implantation rates of devices for HF, in particular ICD and CRT-D, have increased significantly between 2004 and 2008 in Europe, but there remain major differences between countries.
- Device therapy
- Geographic differences
- Heart failure
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine